MarketWatch.com - Top Stories MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.
- Mining giant BHP offers to buy rival Anglo American in potential megadealon April 25, 2024 at 2:27 am
Mining giant BHP has offered to buy Anglo American, a long-time rival with a market capitalization of about $35 billion, in a potential megadeal that could reshape the global mining industry.
- Rubrik prices its IPO at $32, above expected rangeby Emily Bary on April 25, 2024 at 1:51 am
Rubrik Inc. priced its initial public offering late Wednesday at $32 a share.
- Chipotle says it’s seen no impact yet on consumers from California wage increasesby Bill Peters on April 25, 2024 at 1:06 am
Shares of Chipotle Mexican Grill Inc. rose after hours on Wednesday after the fast-casual Mexican food chain reported first-quarter results that beat expectations, helped by demand for limited-time menu items.
- Zuckerberg burns some goodwill on Wall Street as he plows forward with the metaverseby Therese Poletti on April 25, 2024 at 12:54 am
Investors clearly also concerned that Meta’s spending will include a lot more on virtual and augmented reality.
- IBM’s stock heads toward its worst day since 2021 after earningsby Emily Bary on April 25, 2024 at 12:52 am
IBM’s earnings showed continued AI momentum, though overall revenue came in a bit light.
- Ford stock rises as EV losses are held in check and hybrid sales surgeby Claudia Assis on April 25, 2024 at 12:50 am
Carmaker reports a better-than-expected quarter, and EV losses were around Wall Street expectations.
- A new wave of e-commerce disruption could close 45,000 retail stores over the next five years, analysts sayby Bill Peters on April 24, 2024 at 11:40 pm
UBS analysts have suggested that e-commerce isn’t done upending brick-and-mortar retail just yet.
- Cidara Therapeutics shares surge 30% after reacquiring flu treatmenton April 24, 2024 at 11:19 pm
Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates.